Used primarily as an intermediate in pharmaceutical synthesis, especially in the preparation of bioactive molecules and drug candidates. Its structure supports the development of kinase inhibitors and other targeted therapies in oncology. The boronic ester group enables participation in Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing carbon-carbon bonds during the development of complex organic molecules. Commonly employed in research settings for lead optimization and library synthesis in drug discovery programs.